Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma

A 20-year-old woman was diagnosed with stage 4 lung adenocarcinoma with an epidermal growth factor receptor (EGFR) exon 20 insertion gene mutation. Although the patient underwent chemotherapy, her lesions progressed. Liquid biopsy for EGFR T790M mutation showed negative results. After administering...

Full description

Saved in:
Bibliographic Details
Published in:EXCLI J
Main Authors: Murano, Chihiro, Igarashi, Akira, Yamauchi, Keiko, Inoue, Sumito, Watanabe, Masafumi
Format: Artigo
Language:Inglês
Published: Leibniz Research Centre for Working Environment and Human Factors 2019
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6806250/
https://ncbi.nlm.nih.gov/pubmed/31645848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17179/excli2019-1786
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items